GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis

NYSE:GRDN • US40145W1018

33.51 USD
+0.44 (+1.33%)
At close: Feb 27, 2026
33.51 USD
0 (0%)
After Hours: 2/27/2026, 7:08:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall GRDN gets a fundamental rating of 5 out of 10. We evaluated GRDN against 101 industry peers in the Health Care Providers & Services industry. GRDN has only an average score on both its financial health and profitability. GRDN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year GRDN was profitable.
  • GRDN had a positive operating cash flow in the past year.
  • Of the past 5 years GRDN 4 years were profitable.
  • Each year in the past 5 years GRDN had a positive operating cash flow.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • GRDN's Return On Assets of 10.32% is amongst the best of the industry. GRDN outperforms 94.06% of its industry peers.
  • GRDN has a better Return On Equity (21.90%) than 88.12% of its industry peers.
  • GRDN's Return On Invested Capital of 20.33% is amongst the best of the industry. GRDN outperforms 94.06% of its industry peers.
Industry RankSector Rank
ROA 10.32%
ROE 21.9%
ROIC 20.33%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • The Profit Margin of GRDN (2.90%) is better than 66.34% of its industry peers.
  • GRDN's Operating Margin of 4.22% is fine compared to the rest of the industry. GRDN outperforms 60.40% of its industry peers.
  • GRDN has a Gross Margin of 19.74%. This is comparable to the rest of the industry: GRDN outperforms 42.57% of its industry peers.
  • In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
Industry RankSector Rank
OM 4.22%
PM (TTM) 2.9%
GM 19.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GRDN is creating value.
  • Compared to 1 year ago, GRDN has more shares outstanding
  • Compared to 5 years ago, GRDN has more shares outstanding
  • Compared to 1 year ago, GRDN has an improved debt to assets ratio.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • GRDN has an Altman-Z score of 10.42. This indicates that GRDN is financially healthy and has little risk of bankruptcy at the moment.
  • GRDN has a Altman-Z score of 10.42. This is amongst the best in the industry. GRDN outperforms 94.06% of its industry peers.
  • GRDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.42
ROIC/WACC2.34
WACC8.68%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

  • GRDN has a Current Ratio of 1.22. This is a normal value and indicates that GRDN is financially healthy and should not expect problems in meeting its short term obligations.
  • GRDN has a Current ratio (1.22) which is in line with its industry peers.
  • GRDN has a Quick Ratio of 1.22. This is a bad value and indicates that GRDN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GRDN has a Quick ratio of 0.93. This is in the lower half of the industry: GRDN underperforms 68.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.93
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 139.38% over the past year.
  • GRDN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.22%.
  • The Revenue has been growing by 11.96% on average over the past years. This is quite good.
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%

3.2 Future

  • Based on estimates for the next years, GRDN will show a very strong growth in Earnings Per Share. The EPS will grow by 33.35% on average per year.
  • Based on estimates for the next years, GRDN will show a quite strong growth in Revenue. The Revenue will grow by 8.73% on average per year.
EPS Next Y158.33%
EPS Next 2Y69.19%
EPS Next 3Y43.76%
EPS Next 5Y33.35%
Revenue Next Year17.72%
Revenue Next 2Y8.39%
Revenue Next 3Y8.91%
Revenue Next 5Y8.73%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 53.19, GRDN can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as GRDN.
  • GRDN is valuated expensively when we compare the Price/Earnings ratio to 27.10, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 31.74, which means the current valuation is very expensive for GRDN.
  • The rest of the industry has a similar Price/Forward Earnings ratio as GRDN.
  • GRDN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 53.19
Fwd PE 31.74
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as GRDN.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as GRDN.
Industry RankSector Rank
P/FCF 31.12
EV/EBITDA 25.58
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GRDN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as GRDN's earnings are expected to grow with 43.76% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y69.19%
EPS Next 3Y43.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • GRDN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (2/27/2026, 7:08:12 PM)

After market: 33.51 0 (0%)

33.51

+0.44 (+1.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10
Earnings (Next)03-11
Inst Owners57.53%
Inst Owner Change-0.95%
Ins Owners8.89%
Ins Owner Change74.94%
Market Cap2.12B
Revenue(TTM)1.39B
Net Income(TTM)40.24M
Analysts86
Price Target35.7 (6.54%)
Short Float %8.32%
Short Ratio6.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.47%
Min EPS beat(2)-13.49%
Max EPS beat(2)-11.45%
EPS beat(4)1
Avg EPS beat(4)-7.59%
Min EPS beat(4)-18.3%
Max EPS beat(4)12.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)2.36%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.94%
PT rev (3m)2.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.94%
EPS NY rev (1m)3.96%
EPS NY rev (3m)4.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.73%
Valuation
Industry RankSector Rank
PE 53.19
Fwd PE 31.74
P/S 1.53
P/FCF 31.12
P/OCF 24.11
P/B 11.55
P/tB 24.88
EV/EBITDA 25.58
EPS(TTM)0.63
EY1.88%
EPS(NY)1.06
Fwd EY3.15%
FCF(TTM)1.08
FCFY3.21%
OCF(TTM)1.39
OCFY4.15%
SpS21.95
BVpS2.9
TBVpS1.35
PEG (NY)0.34
PEG (5Y)N/A
Graham Number6.41
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 21.9%
ROCE 25.73%
ROIC 20.33%
ROICexc 24.2%
ROICexgc 49.8%
OM 4.22%
PM (TTM) 2.9%
GM 19.74%
FCFM 4.91%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-Score6
Asset Turnover3.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 91.13%
Cap/Sales 1.43%
Interest Coverage 75.25
Cash Conversion 109.39%
Profit Quality 169.42%
Current Ratio 1.22
Quick Ratio 0.93
Altman-Z 10.42
F-Score6
WACC8.68%
ROIC/WACC2.34
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
EPS Next Y158.33%
EPS Next 2Y69.19%
EPS Next 3Y43.76%
EPS Next 5Y33.35%
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%
Revenue Next Year17.72%
Revenue Next 2Y8.39%
Revenue Next 3Y8.91%
Revenue Next 5Y8.73%
EBIT growth 1Y251.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year264.98%
EBIT Next 3Y58.03%
EBIT Next 5Y43.45%
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%

GUARDIAN PHRMCY SERVICES-A / GRDN FAQ

Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?

ChartMill assigns a fundamental rating of 5 / 10 to GRDN.


What is the valuation status of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

ChartMill assigns a valuation rating of 4 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Fairly Valued.


How profitable is GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 6 / 10.


What is the financial health of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?

The financial health rating of GUARDIAN PHRMCY SERVICES-A (GRDN) is 6 / 10.